Denmark Biotechnology & Medical Research

Gubra A/S (GUBRA)

Track

Track

Gubra A/S has recorded no insider trading activity within the past three months. The most recent transactions occurred on June 16, 2026, when the Chief Executive Officer and Chief Financial Officer acquired shares. Prior to this, board members engaged in multiple purchase events throughout late 2025 and early 2026.
Ticker: GUBRA Exchange: CPH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Gubra A/S. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Markus Rohrwild Chief Executive Officer Officer
Transaction date
Purchase
Price
191.22
Quantity 90,991
Value DKK3,491,210
Kristian Borbos Chief Financial Officer Officer
Transaction date
Purchase
Price
240.41
Quantity 37,358
Value DKK1,052,552
1.7
Niels Vrang Board member in Gubra Director
Transaction date
Purchase
Price
450.57
Quantity 15,734
Value DKK210,400
1.7
Niels Vrang Board member Director
Transaction date
Purchase
Price
381.37
Quantity 20,000
Value DKK7,627,450
1.7
Niels Vrang Board member Director
Transaction date
Purchase
Price
488.00
Quantity 10,000
Value DKK4,879,977
2.3
Monika Lessl Chairman Director
Transaction date
Purchase
Price
392.61
Quantity 379
Value DKK148,801
2.4
Jacob Jelsing Board member Director
Transaction date
Purchase
Price
386.34
Quantity 38,792
Value DKK14,987,001
2.4
Markus Rohrwild CEO Officer
Transaction date
Purchase
Price
373.61
Quantity 4,300
Value DKK1,606,506
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
2.4
Markus Rohrwild

Chief Executive Officer

Officer
90,991
191.22
DKK3,491,210 		90,991 191.22 DKK3,491,210
2026-06-17 2026-06-16 B Purchase
Kristian Borbos

Chief Financial Officer

Officer
37,358
240.41
DKK1,052,552 		37,358 240.41 DKK1,052,552
2026-05-11 2026-05-08 B Purchase
1.7
Niels Vrang

Board member in Gubra

Director
15,734
450.57
DKK210,400 		15,734 450.57 DKK210,400
2026-03-02 2026-03-02 B Purchase
1.7
Niels Vrang

Board member

Director
20,000
381.37
DKK7,627,450 		20,000 381.37 DKK7,627,450
2025-12-17 2025-12-17 B Purchase
1.7
Niels Vrang

Board member

Director
10,000
488.00
DKK4,879,977 		10,000 488.00 DKK4,879,977
2025-11-10 2025-11-07 B Purchase
2.3
Monika Lessl

Chairman

Director
379
392.61
DKK148,801 		379 392.61 DKK148,801
2025-11-10 2025-11-07 B Purchase
2.4
Jacob Jelsing

Board member

Director
38,792
386.34
DKK14,987,001 		38,792 386.34 DKK14,987,001
2025-11-07 2025-11-07 B Purchase
2.4
Markus Rohrwild

CEO

Officer
4,300
373.61
DKK1,606,506 		4,300 373.61 DKK1,606,506
Explore more

More insider trading research around Gubra A/S

More insider trades in Denmark
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe